Tocilizumab efficacy and safety in rheumatoid arthritis patients after inadequate response to disease-modifying anti-rheumatic drugs or anti-tumor necrosis factor (vol 36, pg 190, 2016)

Journal article

Peer reviewed

Omer Ahmad Fatheddin Abdulkader, Khalid Qushmaq and Faiza Aljishi

Annals of Saudi medicine, Vol.37(4), pp.339-339

01/07/2017

Abstract

General & Internal Medicine

Life Sciences & Biomedicine

Medicine, General & Internal

Science & Technology

1 Record Views

Title: Tocilizumab efficacy and safety in rheumatoid arthritis patients after inadequate response to disease-modifying anti-rheumatic drugs or anti-tumor necrosis factor (vol 36, pg 190, 2016)
Creators - without role: Omer Ahmad Fatheddin Abdulkader - King Abdul Aziz Univ Hosp, Jeddah, Saudi Arabia
Khalid Qushmaq - College Station Medical Center
Faiza Aljishi - King Fahad Specialist Hosp, Dammam, Saudi Arabia
Publication Details: Annals of Saudi medicine, Vol.37(4), pp.339-339
Publisher: K Faisal Spec Hosp Res Centre
Number of pages: 1
Grant note: Hoffmann-La Roche Ltd; Hoffmann-La Roche
Identifiers: 9939892308331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article